Calcium antagonists in cardiovascular disease: rationale for 24-hour action. Proceedings of an official satellite symposium and papers on amlodipine presented at the 25th Anniversary International Symposium on Calcium Antagonists in Hypertension. Basel, Switzerland, February 11-12, 1988
- PMID: 2467114
Item in Clipboard
Calcium antagonists in cardiovascular disease: rationale for 24-hour action. Proceedings of an official satellite symposium and papers on amlodipine presented at the 25th Anniversary International Symposium on Calcium Antagonists in Hypertension. Basel, Switzerland, February 11-12, 1988
J Cardiovasc Pharmacol.
1988.
No abstract available
Similar articles
-
Calcium antagonists into the nineties: appraisal and future trends. Verapamil satellite symposium to the 25th anniversary International Symposium on Calcium Antagonists. Basel, Switzerland, February 12, 1988.J Cardiovasc Pharmacol. 1989;13 Suppl 4:S1-82. J Cardiovasc Pharmacol. 1989. PMID: 2475675 No abstract available.
-
Profiles of calcium antagonists in cardiovascular disease with special reference to second-generation agents and amlodipine.Postgrad Med J. 1991;67 Suppl 5:S2-8. Postgrad Med J. 1991. PMID: 1666430 Review.
-
Calcium antagonists in hypertension. 25th anniversary international symposium. Basel, Switzerland, February 11-12, 1988.J Cardiovasc Pharmacol. 1988;12 Suppl 6:S1-224. J Cardiovasc Pharmacol. 1988. PMID: 2468887 No abstract available.
-
Amlodipine in cardiovascular disease: the need for 24-hour protection and control. Proceedings of a meeting, Hong Kong, February 17, 1990.Postgrad Med J. 1991;67 Suppl 5:S1-62. Postgrad Med J. 1991. PMID: 1687078 No abstract available.
-
Calcium-channel antagonists in cardiovascular disease.Br J Hosp Med. 1997 Jun 4-17;57(11):552-6. Br J Hosp Med. 1997. PMID: 9307671 Review.